Capital Advisor Network’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.9K Buy
17
+1
+6% +$756 0.02% 116
2026
Q2
$10K Sell
16
-22
-58% -$15K 0.01% 124
2026
Q1
$29.4K Buy
+38
New +$29.1K 0.04% 74

Other funds holding REGN

Capital Advisor Network's REGN Position: Q3 2026 in Review

Capital Advisor Network increased its Regeneron Pharmaceuticals (REGN) stake by 6.3% in Q3 2026, buying an estimated $756 and bringing the position to 17 shares worth $12.9K. The position accounts for 0.02% of the portfolio, ranked #116.

Capital Advisor Network first reported a position in REGN in Q1 2026 and has held it in 3 quarters since. The position peaked at $29.4K in Q1 2026. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Capital Advisor Network held 17 shares of Regeneron Pharmaceuticals worth $12.9K as of Q3 2026.
  • Capital Advisor Network bought 1 Regeneron Pharmaceuticals share in Q3 2026, an estimated $756.
  • Regeneron Pharmaceuticals made up 0.02% of Capital Advisor Network's portfolio in Q3 2026, its #116 holding.
  • Capital Advisor Network first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Capital Advisor Network's Regeneron Pharmaceuticals position peaked at $29.4K in Q1 2026.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Capital Advisor Network's 13F filing for Q3 2026, filed 13 Nov 2026.